|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5000 AUD | +2.04% |
|
-2.91% | -23.08% |
| Market Cap | 145M 102M 88.08M 81.17M 75.98M 142M 9.69B 958M 374M 4.72B 383M 375M 16.34B | P/E Ratio 2026 * |
-7.04x | P/E Ratio 2027 * | -4.61x |
|---|---|---|---|---|---|
| Enterprise Value | 153M 108M 93.05M 85.74M 80.26M 150M 10.24B 1.01B 395M 4.98B 404M 396M 17.26B | EV / Sales 2026 * |
19.9x | EV / Sales 2027 * | 20.1x |
| Free-Float |
57.05% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +2.04% | ||
| 1 week | -2.91% | ||
| Current month | -9.09% | ||
| 1 month | +5.26% | ||
| 3 months | +12.36% | ||
| 6 months | -13.79% | ||
| Current year | -23.08% |
| 1 week | 0.49 |  | 0.52 |
| 1 month | 0.46 | | 0.59 |
| Current year | 0.42 | | 0.73 |
| 1 year | 0.28 | | 0.73 |
| 3 years | 0.28 | | 0.78 |
| 5 years | 0.28 | | 1.38 |
| 10 years | 0.13 | | 1.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Graham
CEO | Chief Executive Officer | - | 2020-08-27 |
Justin Reynolds
DFI | Director of Finance/CFO | - | - |
Michele Dilizia
CTO | Chief Tech/Sci/R&D Officer | - | 2020-09-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Michele Dilizia
BRD | Director/Board Member | - | 2012-09-30 |
James Graham
BRD | Director/Board Member | - | 2012-04-30 |
| Director/Board Member | - | 2022-08-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 02-23 | Expiration | Chief Executive Officer | 2,250,000 | 0.7781% | ||
| 25-10-13 | Expiration | Chief Executive Officer | 745,962 | 0.3217% | ||
| 24-11-20 | Buy | Director | 1,000,000 | 0.4313% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.04% | -2.91% | +49.25% | -12.28% | 102M | |
| -2.41% | +0.14% | +39.53% | +154.43% | 1,010B | |
| +1.07% | +3.48% | +53.75% | +50.64% | 580B | |
| +1.32% | +0.22% | +18.35% | +65.35% | 402B | |
| +0.77% | 0.00% | +19.99% | +16.80% | 330B | |
| -1.42% | -1.44% | +45.50% | +8.37% | 294B | |
| -0.85% | -2.86% | +22.05% | +13.80% | 280B | |
| +0.44% | +3.48% | +24.48% | +34.39% | 281B | |
| +1.66% | +1.20% | -44.67% | -47.49% | 197B | |
| +0.32% | +1.61% | +19.48% | +63.42% | 192B | |
| Average | -0.05% | +0.60% | +24.77% | +34.74% | 356.71B | |
| Weighted average by Cap. | -0.80% | +1.00% | +29.84% | +66.16% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.68M 5.41M 4.68M 4.31M 4.03M 7.56M 515M 50.88M 19.84M 250M 20.32M 19.88M 867M | 8.86M 6.25M 5.4M 4.97M 4.66M 8.73M 594M 58.74M 22.9M 289M 23.46M 22.96M 1B |
| Net income | -20.45M -14.42M -12.46M -11.48M -10.74M -20.14M -1.37B -136M -52.84M -667M -54.12M -52.97M -2.31B | -30.9M -21.8M -18.82M -17.35M -16.24M -30.43M -2.07B -205M -79.86M -1.01B -81.8M -80.06M -3.49B |
| Net Debt | 8.15M 5.75M 4.96M 4.58M 4.28M 8.03M 546M 54.02M 21.06M 266M 21.57M 21.11M 921M | 33.53M 23.65M 20.43M 18.82M 17.62M 33.02M 2.25B 222M 86.65M 1.09B 88.76M 86.87M 3.79B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-12 | 0.5000 $ | +2.04% | 85,743 |
| 26-06-11 | 0.4900 $ | -4.85% | 188,481 |
| 26-06-10 | 0.5150 $ | +0.98% | 30,225 |
| 26-06-09 | 0.5100 $ | -0.97% | 280,740 |
| 26-06-05 | 0.5150 $ | -1.90% | 63,757 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- RCE Stock
Select your edition
All financial news and data tailored to specific country editions
